These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38320587)
1. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome. Efthymiou M; Bertolaccini ML; Cohen H Rheumatology (Oxford); 2024 Feb; 63(SI):SI54-SI63. PubMed ID: 38320587 [TBL] [Abstract][Full Text] [Related]
2. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997 [TBL] [Abstract][Full Text] [Related]
3. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Moore GW; Jones PO; Platton S; Hussain N; White D; Thomas W; Rigano J; Pouplard C; Gray E; Devreese KMJ J Thromb Haemost; 2021 Dec; 19(12):3177-3192. PubMed ID: 34192404 [TBL] [Abstract][Full Text] [Related]
4. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity. Moore GW; Peyrafitte M; Dunois C; Amiral J Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386 [TBL] [Abstract][Full Text] [Related]
5. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients. Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489 [TBL] [Abstract][Full Text] [Related]
7. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Favaloro EJ; Henry BM; Lippi G Semin Thromb Hemost; 2022 Feb; 48(1):55-71. PubMed ID: 34130341 [TBL] [Abstract][Full Text] [Related]
9. Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. Efthymiou M; Mackie IJ; Lane PJ; Andrade D; Willis R; Erkan D; Sciascia S; Krillis S; Bison E; Borges Galhardo Vendramini M; Romay-Penabad Z; Qi M; Tektonidou M; Ugarte A; Chighizola C; Belmont HM; Aguirre MA; Ji L; Branch DW; de Jesus G; Fortin PR; Andreoli L; Petri M; Cervera R; Rodriguez E; Knight JS; Atsumi T; Vega J; Sevim E; Bertolaccini ML; Pengo V; Cohen H; J Thromb Haemost; 2019 Dec; 17(12):2069-2080. PubMed ID: 31364274 [TBL] [Abstract][Full Text] [Related]
10. Testing for Lupus Anticoagulants. Moore GW Semin Thromb Hemost; 2022 Sep; 48(6):643-660. PubMed ID: 35649428 [TBL] [Abstract][Full Text] [Related]
11. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey. Favaloro EJ; Wong RC Pathology; 2009; 41(7):666-75. PubMed ID: 20001347 [TBL] [Abstract][Full Text] [Related]
12. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay. Moore GW; Foxton E; Platton S; Yartey N; White D; MacDonald SG J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725 [TBL] [Abstract][Full Text] [Related]
13. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients. Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903 [TBL] [Abstract][Full Text] [Related]
14. Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test. Moore GW Methods Mol Biol; 2023; 2663():263-274. PubMed ID: 37204716 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome. Kandiah DA; Krilis SA Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148 [TBL] [Abstract][Full Text] [Related]
17. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274 [TBL] [Abstract][Full Text] [Related]
18. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974 [TBL] [Abstract][Full Text] [Related]
19. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction. Lee Y; Gu JY; Kim HK J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477 [TBL] [Abstract][Full Text] [Related]
20. Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. Tripodi A; Cohen H; Devreese KMJ J Thromb Haemost; 2020 Jul; 18(7):1569-1575. PubMed ID: 32619349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]